10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BLUE (Bluebird bio Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Bluebird bio Inc together

I guess you are interested in Bluebird bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Bluebird bio Inc’s Financial Insights
  • 📈 Technical Analysis (TA) – Bluebird bio Inc’s Price Targets

I'm going to help you getting a better view of Bluebird bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Bluebird bio Inc

I send you an email if I find something interesting about Bluebird bio Inc.

1. Quick Overview

1.1. Quick analysis of Bluebird bio Inc (30 sec.)










1.2. What can you expect buying and holding a share of Bluebird bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
12.5%

What is your share worth?

Current worth
$-5.91
Expected worth in 1 year
$-25.20
How sure are you?
22.5%

+ What do you gain per year?

Total Gains per Share
$-19.29
Return On Investment
-388.2%

For what price can you sell your share?

Current Price per Share
$4.97
Expected price per share
$3.2 - $5.8
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bluebird bio Inc (5 min.)




Live pricePrice per Share (EOD)
$4.97
Intrinsic Value Per Share
$-189.64 - $-127.28
Total Value Per Share
$-195.55 - $-133.19

2.2. Growth of Bluebird bio Inc (5 min.)




Is Bluebird bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$57.8m$209.2m-$219.8m-2,083.5%

How much money is Bluebird bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$49.9m-$75.7m$25.7m51.5%
Net Profit Margin-307.0%-785.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Bluebird bio Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#857 / 884

Most Revenue
#208 / 884

Most Profit
#788 / 884

Most Efficient
#618 / 884
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bluebird bio Inc?

Welcome investor! Bluebird bio Inc's management wants to use your money to grow the business. In return you get a share of Bluebird bio Inc.

First you should know what it really means to hold a share of Bluebird bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Bluebird bio Inc is $4.97. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bluebird bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bluebird bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-5.91. Based on the TTM, the Book Value Change Per Share is $-4.82 per quarter. Based on the YOY, the Book Value Change Per Share is $2.49 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bluebird bio Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.97-59.7%-1.41-28.3%-4.37-88.0%-2.07-41.7%-2.24-45.0%-2.30-46.3%
Usd Book Value Change Per Share-5.42-109.0%-4.82-97.0%2.4950.0%-0.79-15.9%-1.30-26.2%-0.51-10.3%
Usd Dividend Per Share0.000.0%0.000.0%0.051.1%0.030.5%0.142.7%0.071.4%
Usd Total Gains Per Share-5.42-109.0%-4.82-97.0%2.5451.1%-0.76-15.3%-1.17-23.5%-0.44-8.9%
Usd Price Per Share4.88-3.68-2.25-3.69-14.93-60.63-
Price to Earnings Ratio-0.41--1.35--0.62--0.16--3.05--7.65-
Price-to-Total Gains Ratio-0.90--5.58--2.73--2.47--4.31--14.80-
Price to Book Ratio-0.83--5.59-0.72--0.88-0.24-2.06-
Price-to-Total Gains Ratio-0.90--5.58--2.73--2.47--4.31--14.80-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.97
Number of shares201
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.14
Usd Book Value Change Per Share-4.82-1.30
Usd Total Gains Per Share-4.82-1.17
Gains per Quarter (201 shares)-969.40-234.50
Gains per Year (201 shares)-3,877.61-937.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-3878-3888110-1048-948
20-7755-7766220-2096-1886
30-11633-11644329-3143-2824
40-15510-15522439-4191-3762
50-19388-19400549-5239-4700
60-23266-23278659-6287-5638
70-27143-27156769-7335-6576
80-31021-31034878-8382-7514
90-34898-34912988-9430-8452
100-38776-387901098-10478-9390

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%2.018.00.010.0%2.038.00.05.0%2.051.01.03.7%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%4.016.00.020.0%9.031.00.022.5%15.037.02.027.8%
Dividend per Share0.00.04.00.0%4.00.08.033.3%5.00.015.025.0%5.00.035.012.5%5.00.049.09.3%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%4.016.00.020.0%9.031.00.022.5%15.037.02.027.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Bluebird bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---5.417-4.823-11%2.487-318%-0.790-85%-1.303-76%-0.512-91%
Book Value Per Share---5.909-1.416-76%9.487-162%3.534-267%8.380-171%17.513-134%
Current Ratio--0.5540.557-1%1.505-63%1.269-56%2.601-79%7.350-92%
Debt To Asset Ratio--1.1961.045+14%0.670+78%0.781+53%0.590+103%0.387+209%
Debt To Equity Ratio---2.323-100%2.264-100%2.132-100%1.463-100%0.847-100%
Dividend Per Share----0%0.053-100%0.027-100%0.137-100%0.068-100%
Enterprise Value---227291795.200-193503527.513-15%-138907871.600-39%-22320420.538-90%1031097398.313-122%3381416292.316-107%
Eps---2.969-1.409-53%-4.374+47%-2.070-30%-2.238-25%-2.303-22%
Ev To Ebitda Ratio--2.3090.723+219%-0.605+126%0.803+188%-3.845+267%-9.491+511%
Ev To Sales Ratio---1.468-3.464+136%-2.270+55%226.901-101%160.488-101%217.667-101%
Free Cash Flow Per Share---4.524-1.857-59%-2.753-39%-1.861-59%-1.893-58%-1.950-57%
Free Cash Flow To Equity Per Share---1.796-1.086-40%0.588-406%-0.329-82%-0.583-68%0.202-989%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.013-1%
Intrinsic Value_10Y_max---127.278----------
Intrinsic Value_10Y_min---189.643----------
Intrinsic Value_1Y_max---8.224----------
Intrinsic Value_1Y_min---9.765----------
Intrinsic Value_3Y_max---28.162----------
Intrinsic Value_3Y_min---37.516----------
Intrinsic Value_5Y_max---52.263----------
Intrinsic Value_5Y_min---74.014----------
Market Cap48668526.200+2%47787204.800169715472.488-72%178819878.400-73%261138912.796-82%991472348.313-95%2979270942.316-98%
Net Profit Margin---0.751-3.070+309%-7.857+946%-54.036+7096%-44.779+5863%-33.079+4305%
Operating Margin----2.6250%-4.1480%-74.3580%-55.2770%-38.4230%
Operating Ratio--1.5564.258-63%10.157-85%82.567-98%61.631-97%46.763-97%
Pb Ratio-0.841-2%-0.826-5.587+576%0.723-214%-0.882+7%0.237-448%2.060-140%
Pe Ratio-0.419-2%-0.411-1.349+228%-0.616+50%-0.156-62%-3.053+643%-7.652+1762%
Price Per Share4.970+2%4.8803.681+33%2.248+117%3.690+32%14.925-67%60.630-92%
Price To Free Cash Flow Ratio-0.275-2%-0.270-0.817+203%-0.683+153%-0.979+263%-0.283+5%-9.179+3304%
Price To Total Gains Ratio-0.917-2%-0.901-5.578+519%-2.734+203%-2.467+174%-4.314+379%-14.796+1542%
Quick Ratio--0.2540.319-20%0.983-74%1.157-78%3.425-93%11.117-98%
Return On Assets---0.098-0.110+12%-0.120+22%-0.094-5%-0.116+18%-0.094-4%
Return On Equity----0.3840%-0.3910%-0.3200%-0.2840%-0.1870%
Total Gains Per Share---5.417-4.823-11%2.540-313%-0.763-86%-1.167-78%-0.444-92%
Usd Book Value---57866000.000-10551250.000-82%209284500.000-128%140415750.000-141%496902700.000-112%867640600.000-107%
Usd Book Value Change Per Share---5.417-4.823-11%2.487-318%-0.790-85%-1.303-76%-0.512-91%
Usd Book Value Per Share---5.909-1.416-76%9.487-162%3.534-267%8.380-171%17.513-134%
Usd Dividend Per Share----0%0.053-100%0.027-100%0.137-100%0.068-100%
Usd Enterprise Value---227291795.200-193503527.513-15%-138907871.600-39%-22320420.538-90%1031097398.313-122%3381416292.316-107%
Usd Eps---2.969-1.409-53%-4.374+47%-2.070-30%-2.238-25%-2.303-22%
Usd Free Cash Flow---44301000.000-57617250.000+30%-58204000.000+31%-65919250.000+49%-92918300.000+110%-95339200.000+115%
Usd Free Cash Flow Per Share---4.524-1.857-59%-2.753-39%-1.861-59%-1.893-58%-1.950-57%
Usd Free Cash Flow To Equity Per Share---1.796-1.086-40%0.588-406%-0.329-82%-0.583-68%0.202-989%
Usd Market Cap48668526.200+2%47787204.800169715472.488-72%178819878.400-73%261138912.796-82%991472348.313-95%2979270942.316-98%
Usd Price Per Share4.970+2%4.8803.681+33%2.248+117%3.690+32%14.925-67%60.630-92%
Usd Profit---29069000.000-49995500.000+72%-75739250.000+161%-50505000.000+74%-98274000.000+238%-106361750.000+266%
Usd Revenue--38712000.00025986500.000+49%11422250.000+239%12805666.667+202%21451650.000+80%14986650.000+158%
Usd Total Gains Per Share---5.417-4.823-11%2.540-313%-0.763-86%-1.167-78%-0.444-92%
 EOD+6 -2MRQTTM+11 -24YOY+14 -233Y+10 -275Y+11 -2610Y+10 -28

3.3 Fundamental Score

Let's check the fundamental score of Bluebird bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.419
Price to Book Ratio (EOD)Between0-1-0.841
Net Profit Margin (MRQ)Greater than0-0.751
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.254
Current Ratio (MRQ)Greater than10.554
Debt to Asset Ratio (MRQ)Less than11.196
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.098
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Bluebird bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.842
Ma 20Greater thanMa 504.451
Ma 50Greater thanMa 1004.403
Ma 100Greater thanMa 2005.310
OpenGreater thanClose4.740
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Bluebird bio Inc

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes gene therapies for curative severe genetic diseases in the United States. The company's product candidates for severe genetic diseases include ZYNTEGLO (betibeglogene autotemcel) for the treatment of transfusion-dependent ß-thalassemia; LYFGENIA (lovotibeglogene autotemcel) for the treatment of sickle cell disease (SCD) and a history of vaso-occlusive events; and SKYSONA (elivaldogene autotemcel) to treat cerebral adrenoleukodystrophy. Its clinical development programs include HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Somerville, Massachusetts. As of May 29, 2025, bluebird bio, Inc. was taken private.

Fundamental data was last updated by Penke on 2025-06-19 01:16:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Bluebird bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of -75.1% means that $-0.75 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bluebird bio Inc:

  • The MRQ is -75.1%. The company is making a huge loss. -2
  • The TTM is -307.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-75.1%TTM-307.0%+231.9%
TTM-307.0%YOY-785.7%+478.6%
TTM-307.0%5Y-4,477.9%+4,170.9%
5Y-4,477.9%10Y-3,307.9%-1,170.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-75.1%-92.7%+17.6%
TTM-307.0%-141.4%-165.6%
YOY-785.7%-186.1%-599.6%
3Y-5,403.6%-248.3%-5,155.3%
5Y-4,477.9%-338.6%-4,139.3%
10Y-3,307.9%-488.9%-2,819.0%
4.3.1.2. Return on Assets

Shows how efficient Bluebird bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • -9.8% Return on Assets means that Bluebird bio Inc generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bluebird bio Inc:

  • The MRQ is -9.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.8%TTM-11.0%+1.2%
TTM-11.0%YOY-12.0%+1.0%
TTM-11.0%5Y-11.6%+0.5%
5Y-11.6%10Y-9.4%-2.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.8%-11.5%+1.7%
TTM-11.0%-11.6%+0.6%
YOY-12.0%-11.4%-0.6%
3Y-9.4%-11.8%+2.4%
5Y-11.6%-12.1%+0.5%
10Y-9.4%-13.8%+4.4%
4.3.1.3. Return on Equity

Shows how efficient Bluebird bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Bluebird bio Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bluebird bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-38.4%+38.4%
TTM-38.4%YOY-39.1%+0.6%
TTM-38.4%5Y-28.4%-10.0%
5Y-28.4%10Y-18.7%-9.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.6%+13.6%
TTM-38.4%-14.9%-23.5%
YOY-39.1%-14.4%-24.7%
3Y-32.0%-17.0%-15.0%
5Y-28.4%-17.9%-10.5%
10Y-18.7%-20.1%+1.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Bluebird bio Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Bluebird bio Inc is operating .

  • Measures how much profit Bluebird bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bluebird bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-262.5%+262.5%
TTM-262.5%YOY-414.8%+152.3%
TTM-262.5%5Y-5,527.7%+5,265.2%
5Y-5,527.7%10Y-3,842.3%-1,685.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--229.2%+229.2%
TTM-262.5%-250.3%-12.2%
YOY-414.8%-205.1%-209.7%
3Y-7,435.8%-220.2%-7,215.6%
5Y-5,527.7%-342.6%-5,185.1%
10Y-3,842.3%-475.5%-3,366.8%
4.3.2.2. Operating Ratio

Measures how efficient Bluebird bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.56 means that the operating costs are $1.56 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bluebird bio Inc:

  • The MRQ is 1.556. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.258. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.556TTM4.258-2.703
TTM4.258YOY10.157-5.899
TTM4.2585Y61.631-57.373
5Y61.63110Y46.763+14.868
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5562.110-0.554
TTM4.2582.704+1.554
YOY10.1573.063+7.094
3Y82.5673.576+78.991
5Y61.6314.713+56.918
10Y46.7636.512+40.251
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Bluebird bio Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bluebird bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.55 means the company has $0.55 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bluebird bio Inc:

  • The MRQ is 0.554. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.557. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.554TTM0.557-0.003
TTM0.557YOY1.505-0.948
TTM0.5575Y2.601-2.044
5Y2.60110Y7.350-4.749
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5543.661-3.107
TTM0.5573.786-3.229
YOY1.5054.121-2.616
3Y1.2694.680-3.411
5Y2.6015.765-3.164
10Y7.3506.150+1.200
4.4.3.2. Quick Ratio

Measures if Bluebird bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.25 means the company can pay off $0.25 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bluebird bio Inc:

  • The MRQ is 0.254. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.319. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.254TTM0.319-0.065
TTM0.319YOY0.983-0.664
TTM0.3195Y3.425-3.106
5Y3.42510Y11.117-7.692
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2542.826-2.572
TTM0.3193.128-2.809
YOY0.9833.782-2.799
3Y1.1574.304-3.147
5Y3.4255.703-2.278
10Y11.1176.454+4.663
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Bluebird bio Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Bluebird bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Bluebird bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 1.20 means that Bluebird bio Inc assets are financed with 119.6% credit (debt) and the remaining percentage (100% - 119.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Bluebird bio Inc:

  • The MRQ is 1.196. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 1.045. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ1.196TTM1.045+0.151
TTM1.045YOY0.670+0.375
TTM1.0455Y0.590+0.455
5Y0.59010Y0.387+0.203
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1960.324+0.872
TTM1.0450.347+0.698
YOY0.6700.327+0.343
3Y0.7810.339+0.442
5Y0.5900.349+0.241
10Y0.3870.382+0.005
4.5.4.2. Debt to Equity Ratio

Measures if Bluebird bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bluebird bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.323-2.323
TTM2.323YOY2.264+0.059
TTM2.3235Y1.463+0.860
5Y1.46310Y0.847+0.616
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.383-0.383
TTM2.3230.436+1.887
YOY2.2640.410+1.854
3Y2.1320.446+1.686
5Y1.4630.460+1.003
10Y0.8470.509+0.338
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Bluebird bio Inc generates.

  • Above 15 is considered overpriced but always compare Bluebird bio Inc to the Biotechnology industry mean.
  • A PE ratio of -0.41 means the investor is paying $-0.41 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bluebird bio Inc:

  • The EOD is -0.419. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.411. Based on the earnings, the company is expensive. -2
  • The TTM is -1.349. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.419MRQ-0.411-0.008
MRQ-0.411TTM-1.349+0.938
TTM-1.349YOY-0.616-0.733
TTM-1.3495Y-3.053+1.703
5Y-3.05310Y-7.652+4.599
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.419-2.197+1.778
MRQ-0.411-2.027+1.616
TTM-1.349-2.527+1.178
YOY-0.616-3.733+3.117
3Y-0.156-3.717+3.561
5Y-3.053-6.036+2.983
10Y-7.652-6.649-1.003
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bluebird bio Inc:

  • The EOD is -0.275. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.270. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.817. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.275MRQ-0.270-0.005
MRQ-0.270TTM-0.817+0.547
TTM-0.817YOY-0.683-0.133
TTM-0.8175Y-0.283-0.534
5Y-0.28310Y-9.179+8.896
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.275-3.007+2.732
MRQ-0.270-2.704+2.434
TTM-0.817-3.627+2.810
YOY-0.683-4.334+3.651
3Y-0.979-5.070+4.091
5Y-0.283-8.532+8.249
10Y-9.179-9.305+0.126
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Bluebird bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.83 means the investor is paying $-0.83 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bluebird bio Inc:

  • The EOD is -0.841. Based on the equity, the company is expensive. -2
  • The MRQ is -0.826. Based on the equity, the company is expensive. -2
  • The TTM is -5.587. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.841MRQ-0.826-0.015
MRQ-0.826TTM-5.587+4.761
TTM-5.587YOY0.723-6.310
TTM-5.5875Y0.237-5.824
5Y0.23710Y2.060-1.823
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.8411.921-2.762
MRQ-0.8261.843-2.669
TTM-5.5872.113-7.700
YOY0.7232.467-1.744
3Y-0.8822.541-3.423
5Y0.2373.666-3.429
10Y2.0604.311-2.251
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Bluebird bio Inc.

4.8.1. Institutions holding Bluebird bio Inc

Institutions are holding 39.68% of the shares of Bluebird bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31BlackRock Inc7.12770.0001697973-10696-1.5093
2025-03-31Vanguard Group Inc5.29220.0001518238-7176-1.3658
2025-03-31TANG CAPITAL MANAGEMENT LLC4.08480.1084000004000000
2025-03-31Geode Capital Management, LLC2.51330.0001246117126035.3971
2025-03-31State Street Corp2.00340196179-1742-0.8801
2025-03-31EQUITEC PROPRIETARY MARKETS, LLC1.13060.38421107141107140
2024-12-31UBS Group AG1.08550.00021063021013472045.3481
2025-03-31FMR Inc0.89530876674003984.0661
2025-03-31Quinn Opportunity Partners LLC0.83150.027381429814290
2025-03-31Northern Trust Corp0.82110.000180401-1299-1.59
2025-03-31Lion Point Capital, LP0.80582.45667891200
2025-03-31Goldman Sachs Group Inc0.66330.00016495029324.7277
2025-03-31Black Maple Capital Management LP0.61470.164160197601970
2025-03-31Susquehanna International Group, LLP0.57790.000156588565880
2025-03-31SIMPLEX TRADING, LLC0.54260.000253134531340
2025-03-31Bank of New York Mellon Corp0.3345032759368612.6784
2025-03-31Css LLC0.31420.008230772307720
2025-03-31Morgan Stanley - Brokerage Accounts0.2933028723-8748-23.3461
2025-03-31JPMorgan Chase & Co0.2744026870-23856-47.0291
2025-03-31Bank of America Corp0.2678026224-27324-51.0271
Total 30.47393.14942984149+872600+29.2%

4.9.2. Funds holding Bluebird bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-11-30Galileo - Biotech Innovation Fund S USD0.19880.393238927300
2025-04-30Vanguard Total Stock Mkt Idx Inv2.99330.000129312200
2025-04-30ACATIS Datini Valueflex Fonds A1.6850.084116500000
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr1.62950.000615956900
2025-03-31Fidelity Small Cap Index1.0070.00298606-2545-2.516
2025-03-31Stork Fund Dynamic MultiStrategies O EUR0.65280.025263928639280
2025-05-30Fidelity Enhanced Small Cap ETF0.61730.01696045300
2025-04-30Fidelity Extended Market Index0.55080.000653932-516-0.9477
2025-04-30Vanguard Russell 2000 ETF0.4820.00164719623925.3388
2025-03-31NT R2000 Index Fund - NL0.24650.00224138-833-3.3359
2025-04-30Schwab Small Cap Index0.23730.00162323500
2025-03-31Extended Equity Market Fund K0.22680.000822213680.3071
2025-04-30Fidelity Total Market Index0.19720.00011930600
2025-03-31NT R2000 Index Fund - DC - NL - 30.19690.00219283-1088-5.3409
2025-04-30iShares Russell 2000 Small-Cap Idx Instl0.18990.00191859900
2025-04-30SPDR® Russell 2000 US Small Cap ETF0.16780.001916428-1586-8.8043
2025-03-31Russell 2500™ Index Fund F0.15260.000814942-3-0.0201
2025-03-31Russell 2000 Index Non-Lendable Fund E0.14430.002114135220.1559
2025-04-30Fidelity Series Total Market Index0.14180.0001138825834.3838
2025-04-30EQ/2000 Managed Volatility IB0.12790.00171252000
Total 11.84550.53931529760+60422+3.9%

5.3. Insider Transactions

Insiders are holding 0.709% of the shares of Bluebird bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-02-03Andrew ObenshainSELL867.39
2025-02-03Thomas J KlimaSELL1227.39
2025-01-06Andrew ObenshainSELL1409.24
2024-12-10Andrew ObenshainSELL488.4
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Total Other Income Expense Net 11,165-4,1457,020-9676,0531,8007,853-12,215-4,362



5.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets295,957
Total Liabilities353,823
Total Stockholder Equity-57,866
 As reported
Total Liabilities 353,823
Total Stockholder Equity+ -57,866
Total Assets = 295,957

Assets

Total Assets295,957
Total Current Assets174,524
Long-term Assets121,433
Total Current Assets
Cash And Cash Equivalents 78,744
Net Receivables 1,187
Inventory 83,283
Other Current Assets 12,497
Total Current Assets  (as reported)174,524
Total Current Assets  (calculated)175,711
+/- 1,187
Long-term Assets
Property Plant Equipment 87,478
Goodwill 5,646
Intangible Assets 9,315
Long-term Assets Other 18,994
Long-term Assets  (as reported)121,433
Long-term Assets  (calculated)121,433
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities315,078
Long-term Liabilities38,745
Total Stockholder Equity-57,866
Total Current Liabilities
Short-term Debt 76,805
Short Long Term Debt 72,470
Accounts payable 42,624
Other Current Liabilities 153,025
Total Current Liabilities  (as reported)315,078
Total Current Liabilities  (calculated)344,924
+/- 29,846
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt38,869
Long-term Liabilities  (as reported)38,745
Long-term Liabilities  (calculated)38,869
+/- 124
Total Stockholder Equity
Common Stock1,924
Retained Earnings -4,530,112
Accumulated Other Comprehensive Income -1,879
Other Stockholders Equity 4,472,201
Total Stockholder Equity (as reported)-57,866
Total Stockholder Equity (calculated)-57,866
+/-0
Other
Capital Stock1,924
Cash and Short Term Investments 78,744
Common Stock Shares Outstanding 9,751
Liabilities and Stockholders Equity 295,957
Net Debt 36,714
Net Invested Capital 14,604
Net Working Capital -140,554
Property Plant and Equipment Gross 87,478
Short Long Term Debt Total 115,458



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-31
> Total Assets 
30,918
0
0
0
69,322
137,459
234,544
228,262
224,390
209,510
240,622
330,193
556,739
533,816
999,169
1,017,641
1,002,337
978,704
941,667
918,262
1,118,122
1,072,570
1,457,130
1,405,756
1,900,567
1,866,808
1,761,511
2,351,789
2,242,844
2,138,615
2,023,344
1,892,218
1,727,424
1,529,104
2,107,790
1,945,484
1,781,252
1,637,279
1,454,459
1,339,644
593,795
491,071
573,592
520,098
554,902
692,736
663,393
613,608
619,161
631,483
545,193
465,056
460,232
295,957
295,957460,232465,056545,193631,483619,161613,608663,393692,736554,902520,098573,592491,071593,7951,339,6441,454,4591,637,2791,781,2521,945,4842,107,7901,529,1041,727,4241,892,2182,023,3442,138,6152,242,8442,351,7891,761,5111,866,8081,900,5671,405,7561,457,1301,072,5701,118,122918,262941,667978,7041,002,3371,017,641999,169533,816556,739330,193240,622209,510224,390228,262234,544137,45969,32200030,918
   > Total Current Assets 
0
0
0
0
67,784
135,089
230,526
221,467
211,987
195,920
182,869
223,320
479,989
340,836
815,452
713,155
523,965
560,974
582,886
608,835
724,214
667,311
1,118,618
758,707
1,614,302
1,566,358
1,105,744
1,725,348
1,418,997
1,365,032
1,300,780
1,220,032
1,152,174
967,467
1,613,445
1,293,194
1,215,537
1,097,535
903,526
832,325
336,520
254,917
167,458
160,438
199,488
351,071
287,977
247,076
281,685
271,601
203,516
150,811
154,668
174,524
174,524154,668150,811203,516271,601281,685247,076287,977351,071199,488160,438167,458254,917336,520832,325903,5261,097,5351,215,5371,293,1941,613,445967,4671,152,1741,220,0321,300,7801,365,0321,418,9971,725,3481,105,7441,566,3581,614,302758,7071,118,618667,311724,214608,835582,886560,974523,965713,155815,452340,836479,989223,320182,869195,920211,987221,467230,526135,08967,7840000
       Cash And Cash Equivalents 
25,604
0
0
0
67,011
131,836
228,847
216,791
206,279
192,499
175,710
89,603
347,845
133,174
593,299
417,510
164,269
192,588
222,629
245,154
278,887
216,001
686,334
237,962
758,505
456,535
333,949
952,137
402,579
221,738
280,995
300,426
327,214
346,629
1,198,768
324,164
317,705
439,714
353,468
402,461
161,160
106,260
81,499
66,478
113,006
239,045
172,872
165,347
221,755
212,047
144,067
70,651
62,305
78,744
78,74462,30570,651144,067212,047221,755165,347172,872239,045113,00666,47881,499106,260161,160402,461353,468439,714317,705324,1641,198,768346,629327,214300,426280,995221,738402,579952,137333,949456,535758,505237,962686,334216,001278,887245,154222,629192,588164,269417,510593,299133,174347,84589,603175,710192,499206,279216,791228,847131,83667,01100025,604
       Short-term Investments 
3,507
0
0
0
0
0
0
0
0
0
0
125,771
125,710
201,710
217,208
289,954
353,680
360,515
353,170
355,806
425,491
418,067
409,100
490,812
531,604
665,041
743,010
743,158
982,725
1,100,079
972,885
879,529
779,246
564,054
350,614
906,091
833,546
572,722
486,233
375,140
138,343
105,328
51,010
73,155
67,321
79,212
72,431
8,946
0
0
0
0
0
0
0000008,94672,43179,21267,32173,15551,010105,328138,343375,140486,233572,722833,546906,091350,614564,054779,246879,529972,8851,100,079982,725743,158743,010665,041531,604490,812409,100418,067425,491355,806353,170360,515353,680289,954217,208201,710125,710125,77100000000003,507
       Net Receivables 
0
0
0
0
0
0
0
0
693
693
3,106
3,106
1,913
1,913
399
734
0
0
21,228
21,228
8,542
21,228
4,334
2,712
8,377
14,265
4,732
5,920
13,931
19,449
21,473
13,145
12,826
16,575
24,705
27,517
2,372
24,762
16,597
23,246
11,389
11,531
10,476
12,535
10,787
15,539
15,435
23,000
21,651
16,768
14,426
14,303
3,094
1,187
1,1873,09414,30314,42616,76821,65123,00015,43515,53910,78712,53510,47611,53111,38923,24616,59724,7622,37227,51724,70516,57512,82613,14521,47319,44913,9315,9204,73214,2658,3772,7124,33421,2288,54221,22821,228007343991,9131,9133,1063,10669369300000000
       Inventory 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-8,542
8,730
0
13,893
-11,489
-42,532
0
0
-506,123
0
0
0
-131,506
0
0
0
-122,891
18,079
13,502
766
-97,114
0
15,084
7,519
-1,414
3,809
13,642
20,969
22,919
30,305
33,330
53,944
65,017
83,283
83,28365,01753,94433,33030,30522,91920,96913,6423,809-1,4147,51915,0840-97,11476613,50218,079-122,891000-131,506000-506,12300-42,532-11,48913,89308,730-8,54200000000000000000000
   > Long-term Assets 
0
0
0
0
1,538
2,370
4,018
6,795
12,403
13,590
57,753
106,873
76,750
192,980
183,717
304,486
478,372
417,730
358,781
309,427
393,908
405,259
338,512
647,049
286,265
300,450
655,767
626,441
823,847
773,583
722,564
672,186
575,250
561,637
494,345
652,290
565,715
539,744
550,933
507,319
257,275
236,154
406,134
359,660
355,414
341,665
375,416
366,532
337,476
359,882
341,677
314,245
305,564
121,433
121,433305,564314,245341,677359,882337,476366,532375,416341,665355,414359,660406,134236,154257,275507,319550,933539,744565,715652,290494,345561,637575,250672,186722,564773,583823,847626,441655,767300,450286,265647,049338,512405,259393,908309,427358,781417,730478,372304,486183,717192,98076,750106,87357,75313,59012,4036,7954,0182,3701,5380000
       Property Plant Equipment 
728
0
0
0
1,288
2,120
2,515
5,392
10,920
11,984
12,857
14,978
15,740
16,850
16,803
61,564
82,614
96,638
109,299
131,737
156,955
181,720
180,419
182,358
199,606
204,230
219,226
232,863
246,622
298,648
320,114
335,660
337,061
348,389
344,840
346,131
346,850
363,168
349,813
220,180
101,238
123,131
307,297
300,219
291,358
278,871
313,076
304,689
267,049
285,575
267,962
245,691
237,731
87,478
87,478237,731245,691267,962285,575267,049304,689313,076278,871291,358300,219307,297123,131101,238220,180349,813363,168346,850346,131344,840348,389337,061335,660320,114298,648246,622232,863219,226204,230199,606182,358180,419181,720156,955131,737109,29996,63882,61461,56416,80316,85015,74014,97812,85711,98410,9205,3922,5152,1201,288000728
       Goodwill 
0
0
0
0
0
0
0
0
0
0
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
13,128
12,056
5,646
5,646
5,646
5,646
5,646
5,646
5,646
5,646
5,646
5,646
5,646
5,646
5,646
5,646
5,6465,6465,6465,6465,6465,6465,6465,6465,6465,6465,6465,6465,6465,64612,05613,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,12813,1280000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
48,446
18,448
134,430
125,938
194,247
347,814
273,762
203,203
126,681
180,452
165,801
101,625
413,856
324,193
444,782
380,284
323,772
506,123
408,949
287,922
225,932
131,506
107,674
49,411
207,615
122,891
81,115
101,927
193,129
97,114
55,049
40,641
1,407
1,414
0
0
0
0
0
0
0
0
0
0000000001,4141,40740,64155,04997,114193,129101,92781,115122,891207,61549,411107,674131,506225,932287,922408,949506,123323,772380,284444,782324,193413,856101,625165,801180,452126,681203,203273,762347,814194,247125,938134,43018,44848,44600000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
30,100
29,159
28,219
27,278
26,337
25,397
24,456
23,516
22,575
21,634
20,694
19,753
18,812
17,872
16,931
15,991
15,050
14,109
13,169
12,228
16,480
15,397
14,326
13,254
12,183
11,112
10,041
11,469
16,263
11,009
5,644
0
-2,000
0
4,868
5,613
5,490
5,368
10,438
10,244
10,012
9,780
9,547
9,315
9,3159,5479,78010,01210,24410,4385,3685,4905,6134,8680-2,00005,64411,00916,26311,46910,04111,11212,18313,25414,32615,39716,48012,22813,16914,10915,05015,99116,93117,87218,81219,75320,69421,63422,57523,51624,45625,39726,33727,27828,21929,15930,1000000000000
       Long-term Assets Other 
0
0
0
0
250
250
1,503
1,403
1,483
913
1,668
-1,944
1,215
-619
1,112
9,416
10,360
10,686
10,576
16,247
22,679
24,857
24,528
19,835
23,940
24,569
28,079
42,569
44,805
40,630
84,920
82,069
79,229
79,192
74,783
74,304
72,805
70,864
69,802
70,945
53,277
52,328
52,550
52,388
52,128
51,535
51,204
50,829
54,343
58,417
58,057
53,128
52,640
18,994
18,99452,64053,12858,05758,41754,34350,82951,20451,53552,12852,38852,55052,32853,27770,94569,80270,86472,80574,30474,78379,19279,22982,06984,92040,63044,80542,56928,07924,56923,94019,83524,52824,85722,67916,24710,57610,68610,3609,4161,112-6191,215-1,9441,6689131,4831,4031,5032502500000
> Total Liabilities 
4,222
0
0
0
125,069
78,958
73,274
70,562
72,723
65,345
74,866
68,301
65,482
59,317
80,203
128,635
151,841
172,197
182,377
223,749
248,682
257,191
257,111
264,438
277,135
296,607
303,977
350,999
357,774
366,516
386,970
420,508
442,431
408,671
425,759
422,463
426,196
436,946
469,898
469,117
219,518
227,812
393,476
361,241
358,559
337,996
374,374
391,072
424,624
500,437
492,212
470,842
491,766
353,823
353,823491,766470,842492,212500,437424,624391,072374,374337,996358,559361,241393,476227,812219,518469,117469,898436,946426,196422,463425,759408,671442,431420,508386,970366,516357,774350,999303,977296,607277,135264,438257,111257,191248,682223,749182,377172,197151,841128,63580,20359,31765,48268,30174,86665,34572,72370,56273,27478,958125,0690004,222
   > Total Current Liabilities 
2,893
0
0
0
4,628
29,699
30,358
31,490
34,874
33,046
39,547
38,524
42,978
42,013
28,033
33,577
40,368
38,968
40,382
67,591
74,533
72,636
77,838
76,801
95,612
107,756
116,262
131,643
146,431
146,691
162,109
196,031
223,580
184,422
197,181
196,907
203,588
206,315
247,765
266,559
152,993
142,892
148,861
126,727
128,237
115,933
135,016
158,957
200,113
293,573
297,930
296,032
321,462
315,078
315,078321,462296,032297,930293,573200,113158,957135,016115,933128,237126,727148,861142,892152,993266,559247,765206,315203,588196,907197,181184,422223,580196,031162,109146,691146,431131,643116,262107,75695,61276,80177,83872,63674,53367,59140,38238,96840,36833,57728,03342,01342,97838,52439,54733,04634,87431,49030,35829,6994,6280002,893
       Short-term Debt 
0
0
0
0
1,599
1,548
0
0
4,902
0
0
0
14,174
0
16,630
20,723
24,561
25,192
28,896
50,759
50,181
38,248
42,018
815
1,051
1,048
1,214
1,318
1,424
35,132
37,744
39,862
40,350
40,760
41,910
44,436
34,735
56,126
57,338
58,882
46,304
51,020
96,892
87,582
139,408
102,808
135,182
143,368
0
0
196,230
191,292
188,881
76,805
76,805188,881191,292196,23000143,368135,182102,808139,40887,58296,89251,02046,30458,88257,33856,12634,73544,43641,91040,76040,35039,86237,74435,1321,4241,3181,2141,0481,05181542,01838,24850,18150,75928,89625,19224,56120,72316,630014,1740004,902001,5481,5990000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
61,901
0
0
0
120,140
147,555
153,962
155,055
155,800
155,593
155,317
0
0
17,566
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,995
69,843
70,600
71,507
72,470
72,47071,50770,60069,84368,995000000000000000000017,56600155,317155,593155,800155,055153,962147,555120,14000061,9010000000000000000
       Accounts payable 
1,793
0
0
0
2,173
2,227
1,609
1,144
4,359
2,601
2,586
3,641
2,954
2,551
2,339
3,469
6,334
3,136
2,363
6,710
13,664
8,769
14,424
12,309
12,873
12,028
17,936
12,891
17,831
30,241
29,458
41,874
42,995
30,527
26,181
25,309
13,811
20,232
39,294
21,668
25,883
28,350
24,865
18,622
14,867
19,235
10,894
19,852
18,498
19,387
30,591
24,481
34,316
42,624
42,62434,31624,48130,59119,38718,49819,85210,89419,23514,86718,62224,86528,35025,88321,66839,29420,23213,81125,30926,18130,52742,99541,87429,45830,24117,83112,89117,93612,02812,87312,30914,4248,76913,6646,7102,3633,1366,3343,4692,3392,5512,9543,6412,5862,6014,3591,1441,6092,2272,1730001,793
       Other Current Liabilities 
1,100
0
0
0
2,115
2,132
3,409
5,006
5,175
5,190
11,670
9,677
14,649
15,129
20,024
24,219
28,145
29,623
31,810
54,672
54,660
6,059
1,730
41,780
56,014
60,640
69,789
117,434
127,176
69,828
85,423
105,821
131,761
106,780
125,175
126,101
153,542
128,627
148,446
183,479
78,524
61,700
25,469
18,958
-27,540
-10,329
-12,424
-13,916
3,195
9,002
71,109
80,259
98,265
153,025
153,02598,26580,25971,1099,0023,195-13,916-12,424-10,329-27,54018,95825,46961,70078,524183,479148,446128,627153,542126,101125,175106,780131,761105,82185,42369,828127,176117,43469,78960,64056,01441,7801,7306,05954,66054,67231,81029,62328,14524,21920,02415,12914,6499,67711,6705,1905,1755,0063,4092,1322,1150001,100
   > Long-term Liabilities 
0
0
0
0
120,441
49,259
42,916
39,072
37,849
32,299
35,319
29,777
22,504
17,304
52,170
95,058
111,473
133,229
141,995
156,158
174,149
184,555
179,273
187,637
181,523
188,851
187,715
219,356
211,343
219,825
224,861
224,477
218,851
224,249
228,578
225,556
222,608
230,631
222,133
202,558
66,525
84,920
244,615
234,514
230,322
222,063
239,358
232,115
224,511
206,864
194,282
174,810
170,304
38,745
38,745170,304174,810194,282206,864224,511232,115239,358222,063230,322234,514244,61584,92066,525202,558222,133230,631222,608225,556228,578224,249218,851224,477224,861219,825211,343219,356187,715188,851181,523187,637179,273184,555174,149156,158141,995133,229111,47395,05852,17017,30422,50429,77735,31932,29937,84939,07242,91649,259120,4410000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
147,555
153,962
154,240
154,749
154,545
154,103
153,716
153,319
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000153,319153,716154,103154,545154,749154,240153,962147,555000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-1,599
-1,548
0
0
-4,902
0
0
0
-14,174
0
-16,630
-20,723
-24,561
-25,192
-28,896
-50,759
-50,181
-38,248
-42,018
-815
-1,051
-1,048
-1,214
-1,318
-1,424
150,634
156,478
156,095
150,637
159,582
153,609
150,857
158,286
149,639
141,264
122,685
43,280
59,318
196,076
190,631
141,982
170,567
171,675
160,339
333,636
345,347
124,347
106,510
97,850
38,869
38,86997,850106,510124,347345,347333,636160,339171,675170,567141,982190,631196,07659,31843,280122,685141,264149,639158,286150,857153,609159,582150,637156,095156,478150,634-1,424-1,318-1,214-1,048-1,051-815-42,018-38,248-50,181-50,759-28,896-25,192-24,561-20,723-16,6300-14,174000-4,90200-1,548-1,5990000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
208
385
6,449
6,489
6,615
6,935
4,824
48,883
67,220
79,870
89,973
103,407
123,537
3,235
3,309
3,036
2,291
5,500
33,612
65,640
58,024
219,825
7,439
10,268
218,851
224,249
228,578
225,556
222,608
230,631
7,891
202,558
93
84,920
244,615
234,514
92
222,063
239,358
92
92
92
92
1,079
947
92
929471,07992929292239,358222,06392234,514244,61584,92093202,5587,891230,631222,608225,556228,578224,249218,85110,2687,439219,82558,02465,64033,6125,5002,2913,0363,3093,235123,537103,40789,97379,87067,22048,8834,8246,9356,6156,4896,44938520800000000
       Deferred Long Term Liability 
0
0
0
0
0
0
42,916
39,072
37,641
31,914
28,870
23,288
15,889
10,369
47,346
46,175
44,253
53,359
52,022
52,751
50,612
33,765
22,002
30,361
24,483
28,806
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000028,80624,48330,36122,00233,76550,61252,75152,02253,35944,25346,17547,34610,36915,88923,28828,87031,91437,64139,07242,916000000
> Total Stockholder Equity
26,696
0
0
0
-55,747
58,501
161,270
157,700
151,667
144,165
165,756
261,892
491,257
474,499
918,966
889,006
850,496
806,507
759,290
694,513
869,440
815,379
1,200,019
1,141,318
1,623,432
1,570,201
1,457,534
2,000,790
1,885,070
1,772,099
1,636,374
1,471,710
1,284,993
1,120,433
1,682,031
1,523,021
1,355,056
1,200,333
984,561
870,527
374,277
263,259
180,116
158,857
196,343
354,740
289,019
222,536
194,537
131,046
52,981
-5,786
-31,534
-57,866
-57,866-31,534-5,78652,981131,046194,537222,536289,019354,740196,343158,857180,116263,259374,277870,527984,5611,200,3331,355,0561,523,0211,682,0311,120,4331,284,9931,471,7101,636,3741,772,0991,885,0702,000,7901,457,5341,570,2011,623,4321,141,3181,200,019815,379869,440694,513759,290806,507850,496889,006918,966474,499491,257261,892165,756144,165151,667157,700161,27058,501-55,74700026,696
   Common Stock
2
0
0
0
3
167
236
236
239
243
251
287
323
327
360
366
369
369
370
373
407
409
455
458
494
501
502
547
547
551
553
553
554
556
662
663
665
675
676
701
711
714
735
829
830
1,064
1,065
1,071
0
0
1,916
1,917
1,923
1,924
1,9241,9231,9171,916001,0711,0651,06483082973571471170167667566566366255655455355355154754750250149445845540940737337036936936636032732328725124323923623616730002
   Retained Earnings Total Equity0000000-4,038,171-3,965,2630-4,018,735-3,942,215-3,842,077-3,719,925-3,564,873-3,348,057-3,106,355-2,900,547-2,700,673-2,505,928-2,484,463-2,281,852-2,058,505-1,852,472-1,656,690-1,498,808-1,349,785-1,204,303-1,058,308-913,808-796,580-717,775-646,876-577,674-506,310-429,285-370,441-314,167-266,892-223,966-172,171-147,384-127,840-110,810-109,284-98,675-90,594-84,481000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-527
-664
-234,544
-228,262
-1,454
0
0
-74
-71
-123
-53
50
-2,291
-972
-642
-836
-1,149
-1,252
-1,415
-2,097
-4,205
-5,049
-5,394
-5,463
-3,627
-1,792
-819
-2,851
-1,893
-2,799
-2,400
-4,223
-5,505
-5,449
-5,777
-5,906
-2,911
-4,459
-4,416
-4,630
-4,070
-3,086
-2,364
-2,227
0
0
-2,122
-1,511
-2,133
-1,879
-1,879-2,133-1,511-2,12200-2,227-2,364-3,086-4,070-4,630-4,416-4,459-2,911-5,906-5,777-5,449-5,505-4,223-2,400-2,799-1,893-2,851-819-1,792-3,627-5,463-5,394-5,049-4,205-2,097-1,415-1,252-1,149-836-642-972-2,29150-53-123-71-7400-1,454-228,262-234,544-664-5270000
   Capital Surplus 
0
0
0
0
0
0
245,515
248,058
250,103
253,206
276,315
389,519
638,389
646,466
1,142,625
1,155,482
1,166,585
1,177,551
1,188,847
1,201,286
1,447,856
1,463,098
1,918,754
1,939,537
2,540,951
2,633,057
2,666,729
3,355,491
3,386,958
3,430,030
3,489,112
3,532,513
3,568,184
3,607,139
4,189,697
4,227,254
4,260,443
4,311,462
4,337,719
4,440,605
4,096,402
4,109,081
4,126,012
4,181,393
0
4,322,025
4,328,489
0
0
0
0
0
0
0
00000004,328,4894,322,02504,181,3934,126,0124,109,0814,096,4024,440,6054,337,7194,311,4624,260,4434,227,2544,189,6973,607,1393,568,1843,532,5133,489,1123,430,0303,386,9583,355,4912,666,7292,633,0572,540,9511,939,5371,918,7541,463,0981,447,8561,201,2861,188,8471,177,5511,166,5851,155,4821,142,625646,466638,389389,519276,315253,206250,103248,058245,515000000
   Treasury Stock000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
15,267
138,232
480,059
248,058
250,103
253,206
276,315
389,519
638,389
646,466
1,142,625
1,155,482
1,166,585
1,177,551
1,188,847
1,201,286
1,447,856
1,463,098
1,918,754
1,939,537
2,540,951
2,633,057
2,666,729
3,355,491
3,386,958
3,430,030
3,489,112
3,532,513
3,568,184
3,607,139
4,189,697
4,227,254
4,260,443
4,311,462
4,337,719
4,440,605
4,096,402
4,109,081
4,126,012
4,181,393
4,186,086
4,322,025
4,328,489
4,333,594
0
0
4,464,712
4,466,141
4,469,719
4,472,201
4,472,2014,469,7194,466,1414,464,712004,333,5944,328,4894,322,0254,186,0864,181,3934,126,0124,109,0814,096,4024,440,6054,337,7194,311,4624,260,4434,227,2544,189,6973,607,1393,568,1843,532,5133,489,1123,430,0303,386,9583,355,4912,666,7292,633,0572,540,9511,939,5371,918,7541,463,0981,447,8561,201,2861,188,8471,177,5511,166,5851,155,4821,142,625646,466638,389389,519276,315253,206250,103248,058480,059138,23215,2670000



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue83,807
Cost of Revenue-89,380
Gross Profit-5,573-5,573
 
Operating Income (+$)
Gross Profit-5,573
Operating Expense-262,126
Operating Income-270,461-267,699
 
Operating Expense (+$)
Research Development94,252
Selling General Administrative167,874
Selling And Marketing Expenses0
Operating Expense262,126262,126
 
Net Interest Income (+$)
Interest Income8,218
Interest Expense-22,579
Other Finance Cost-0
Net Interest Income-14,361
 
Pretax Income (+$)
Operating Income-270,461
Net Interest Income-14,361
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-240,645-300,277
EBIT - interestExpense = -240,645
-240,645
-218,136
Interest Expense22,579
Earnings Before Interest and Taxes (EBIT)-218,066-218,066
Earnings Before Interest and Taxes (EBITDA)-156,822
 
After tax Income (+$)
Income Before Tax-240,645
Tax Provision-70
Net Income From Continuing Ops-240,715-240,715
Net Income-240,715
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses351,506
Total Other Income/Expenses Net29,81614,361
 

Technical Analysis of Bluebird bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bluebird bio Inc. The general trend of Bluebird bio Inc is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bluebird bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Bluebird bio Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bluebird bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.42 < 5.8 < 5.8.

The bearish price targets are: 3.2.

Know someone who trades $BLUE? Share this with them.👇

Bluebird bio Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bluebird bio Inc. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bluebird bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bluebird bio Inc. The current macd is 0.21616035.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Bluebird bio Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Bluebird bio Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Bluebird bio Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Bluebird bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartBluebird bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bluebird bio Inc. The current adx is 21.36.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Bluebird bio Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Bluebird bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bluebird bio Inc. The current sar is 3.61689814.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Bluebird bio Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bluebird bio Inc. The current rsi is 62.84. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
Bluebird bio Inc Daily Relative Strength Index (RSI) ChartBluebird bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bluebird bio Inc. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Bluebird bio Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Bluebird bio Inc Daily Stochastic Oscillator ChartBluebird bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bluebird bio Inc. The current cci is 48.18.

Bluebird bio Inc Daily Commodity Channel Index (CCI) ChartBluebird bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bluebird bio Inc. The current cmo is 38.27.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Bluebird bio Inc Daily Chande Momentum Oscillator (CMO) ChartBluebird bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bluebird bio Inc. The current willr is -3.27868852.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Bluebird bio Inc Daily Williams %R ChartBluebird bio Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Bluebird bio Inc.

Bluebird bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bluebird bio Inc. The current atr is 0.2431329.

Bluebird bio Inc Daily Average True Range (ATR) ChartBluebird bio Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bluebird bio Inc. The current obv is -10,086,113.

Bluebird bio Inc Daily On-Balance Volume (OBV) ChartBluebird bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bluebird bio Inc. The current mfi is 72.63.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Bluebird bio Inc Daily Money Flow Index (MFI) ChartBluebird bio Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bluebird bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-01-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.

6.3. Candlestick Patterns

Bluebird bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bluebird bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5062.842
Ma 20Greater thanMa 504.451
Ma 50Greater thanMa 1004.403
Ma 100Greater thanMa 2005.310
OpenGreater thanClose4.740
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Bluebird bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Bluebird bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bluebird bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bluebird bio Inc

I send you an email if I find something interesting about Bluebird bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Bluebird bio Inc.

Receive notifications about Bluebird bio Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.